CDH1 and neoplasm: The aim of the present study was to evaluate the prevalence and characterize CDH1 germline mutations in a series of consecutive sporadic GC patients lacking the criteria of HDGC classification, and in a selected population at risk of GC development, to test its utility as a marker to improve early tumor detection.